Today’s In Crisis headlines


(NEW YORK) — Here are today’s In Crisis headlines:

Biden to hold first press conference of presidency today
President Biden will hold his first formal press conference of his presidency in the East Room of the White House this afternoon at 1:15pm ET.  The press conference comes in the wake of two deadly mass shootings and amid a growing immigration crisis at the southern border.  The president on Wednesday announced that Vice President Kamala Harris has been tasked with addressing the latter challenge. 

Accused Boulder, Colorado supermarket shooter to make first court appearance today
Ahmad Al Aliwi Alissa, the 21-year-old man charged in Monday’s fatal shootings at a Boulder, Colorado grocery store, is scheduled to make his first court appearance this morning.   Alissa has been charged with 10 counts of first-degree murder and one count of attempted murder, according to his arrest warrant.  The motive for the mass shooting remains unclear.  The Boulder City Council held a special meeting Wednesday night to hear from the community about Monday’s shooting, while a vigil for the victims was also held Wednesday night.

Atlanta police arrest armed man in Publix grocery store
Atlanta police on Wednesday arrested a man who brought several guns into a Publix grocery store at Atlantic Station.  Rico Marley, 22, is said to have walked into the store in the middle of the afternoon holding a rifle.  Someone saw him with the weapon in the bathroom and alerted store management.  Officers recovered two long guns and three pistols from Marley, as well as body armor.  He’s been charged with reckless conduct and was last known to be held in the Fulton County Jail.  Marley’s arrest comes eight days after eight people were killed and one wounded in a series of shootings at three Atlanta-area spas, and less than three days after ten people were killed in a mass shooting at a Boulder, Colorado grocery store.
New unemployment applications fall to pandemic-low level
The number of new unemployment benefits applications fell last week to its lowest level since the pandemic began.  According to numbers released Thursday morning by the U.S. Labor Department, 684,000 applications for unemployment were filed in the week ending March 20.  That’s a decrease of 97,000 from the previous week’s level, which itself was revised up by 11,000, from 770,000 to 781,000.  There are currently 18,952,795 people in the U.S. claiming unemployment benefits through all government programs.

COVID-19 numbers
Here’s the latest data on COVID-19 coronavirus infections, deaths and vaccinations.

Latest reported COVID-19 numbers globally per Johns Hopkins University
Global diagnosed cases: 124,908,585
Global deaths: 2,745,964.  The United States has the most deaths of any single country, with 545,282.
Number of countries/regions: at least 192
Total patients recovered globally: 70,864,075

Latest reported COVID-19 numbers in the United States per Johns Hopkins University
There are at least 30,011,550 reported cases in 50 states + the District of Columbia, Puerto Rico and Guam.  This is more than in any other country.
U.S. deaths: at least 545,282.  California has the greatest number of reported deaths in the U.S., with 57,975
U.S. total people tested: 385,820,362

The greatest number of reported COVID-19 cases in the U.S. is in California, with 3,649,727 confirmed cases out of a total state population of 39.51 million.  This ranks second in the world after England, which has 3,773,224 cases.  Texas is third, with 2,766,259 confirmed cases out of a total state population of 29 million.

Latest reported COVID-19 vaccination numbers in the United States
The Centers for Disease Control and Prevention reports a total of 169,223,125 COVID-19 vaccine doses have been distributed in the U.S.  Of those, 130,473,853 doses have been administered, with 85,472,166 people receiving at least one dose and 46,365,515 people fully vaccinated, representing 25.7% and 14% of the total U.S. population, respectively. The Moderna and Pfizer/BioNTech vaccines each require two doses to be effective.  The Johnson & Johnson vaccine requires a single dose to be effective.

US tops 30 million COVID-19 cases as downward trend reverses
The U.S. has now recorded more than 30 million total COVID-19 cases since the first was recorded in January, 2020.  Data compiled by Johns Hopkins University reported a total of at least 30,011,550 coronavirus cases as of Thursday morning.  That remains the greatest number of cases in any country, accounting for 24% of global infections.

The country’s daily case average also continues to increase, now standing at just over 56,000 cases a day, about a 3% increase in the last week, according to the Centers for Disease Control and Prevention.  While the national average of hospital admissions has declined by 29% in the last month, it currently appears to have plateaued at an average of approximately 4,600 admissions a day.  The U.S. is currently averaging just under 2.5 million COVID-19 vaccine doses administered a day.

The national daily death average appears to be following a similar trend, plateauing around 1,000 daily deaths day for nearly a week now.  In the last seven days, the U.S. has reported just over 7,100 confirmed deaths.  The total number of U.S. COVID-19 deaths is currently at least 545,282, according to Johns Hopkins University.  This again is the highest number of deaths in any country, accounting for just under 20% of global fatalities.  The CDC is currently forecasting the U.S. will see a total of 558,000 to 578,000 COVID-19 deaths by the week ending April 17.

AstraZeneca releases revised vaccine efficacy data
AstraZeneca insisted Wednesday that its COVID-19 vaccine is strongly effective even after counting additional illnesses in its initial, disputed U.S. study.  In a late-night press release, the pharmaceutical company said it had recalculated data from their Phase III human trials and concluded the vaccine is 76% effective in preventing symptomatic COVID-19, instead of the 79% it had claimed earlier in the week.  Just a day earlier, an independent U.S. panel that oversees the study had accused AstraZeneca of cherry-picking data to tout the protection offered by its vaccine.  The company’s next step is to apply to the Food and Drug Administration for authorization to distribute the vaccine nationally.

Copyright © 2021, ABC Audio. All rights reserved.